
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3

Operating Margin
Ouro Fino Saude Animal Participacoes SA
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
BR |
![]() |
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
|
1.3B BRL |
85%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
687.1B USD |
40%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368.5B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
48%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
206B CHF |
33%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
181.6B CHF |
33%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
161B GBP |
24%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
193.7B USD |
34%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
11%
|
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
116.6B EUR |
22%
|
Ouro Fino Saude Animal Participacoes SA
Glance View
Ouro Fino Saúde Animal Participações SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The firm manufactures veterinary products using scientific technology in the Company's laboratories. The firm's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Ouro Fino Saude Animal Participacoes SA's most recent financial statements, the company has Operating Margin of 84.6%.